Anti-tumoural activity of peripheral blood mononuclear cells against melanoma cells: Discrepant in-vitro and in-vivo effects

Melanoma Research

Volumn 16, Issue 4, 2006, Pages 325-333

  Joseph Pietras, Débora ^a   Carlier, Annie ^a   Madoulet, Claudie ^b   Albert, Philippe ^a,c  

^a UFR Sciences   (France)

^b UFR of Pharmacy   (France)

^c UFR Sciences   (France)

Author keywords

Blood mononuclear cells; Cytotoxicity; Melanoma; Spheroid

Indexed keywords

DOXORUBICIN; FICOLL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CELL DEATH; CELL SIZE; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CENTRIFUGATION; COCULTURE; CONTROLLED STUDY; CYTOLYSIS; FEMALE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; LIFESPAN; MACROPHAGE; MELANOMA CELL; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PUNCTURE; SPHEROID CELL; SURVIVAL RATE; SURVIVAL TIME;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL SURVIVAL; COCULTURE TECHNIQUES; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEUKOCYTES, MONONUCLEAR; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; SKIN NEOPLASMS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 33746263898     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cmr.0000205016.31235.a9     Document Type: Article

References (24)

1. Offringa R, Van der Burg SH, Ossendorp F, Toes RE, Melief CJ. Design and evaluation of antigen-specific vaccination strategies against cancer. Curr Opin Immunol 2000; 12:576-582.
2. Moingeon P. Cancer vaccines. Vaccine 2001; 19:1305-1326.
3. Speiser DE, Pittet MJ, Rimoldi D, Guillaume P, Luescher IF, Lienard D, et al. Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells. Sem Cancer Biol 2003; 13: 461-472.
4. + T cells in patients with melanoma. J Immunol 2000; 164:3402-3412.
5. Butterfield LH, Ribas A, Dissette VB, Amarnani SN, Vu HT, Oseguera D, et al. Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma. Clin Cancer Res 2003; 9:998-1008.
6. + T cells: implications for an efficient vaccination strategy. Genet Ther 2003; 10: 243-250.
7. Durek C, Brandau S, Ulmer AJ, Flad HD, Jocham D, Böhle A. Bacillus-Calmette-Guérin (BCG) and 3D tumors: an in vitro model for the study of adhesion and invasion. J Urol 1999; 162:600-605.
8. Mougel L, Tarpin M, Albert Ph, Le Naour R, Devy J, Kaplan H, et al. Three-dimensional culture and multidrug resistance: effects on immune reactivity of MCF-7 cells by monocytes. Anticancer Res 2004; 24:935-942.
9. Moscow JA, Cowan KH. Multidrug resistance. Cancer chemotherapy. Biol Resp Modif 1990; 11:97-114.
10. Kolchinsky A, Roninson IB. Drug resistance conferred by MDR1 expression in spheroids formed by glioblastoma cell lines. Anticancer Res 1997; 17:3321-3327.
11. Mueller-Kleiser W. Multicellular spheroids. A review on cellular aggregates in cancer research. J. Cancer Res Clin Oncol 1987; 113:101-122.
12. Sutherland RM. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 1988; 240:177-184.
13. Konur A, Kreutz M, Knüchel R, Krause SW, Andreesen R. Three-dimensional co-culture of human monocytes and macrophages with tumor cells: analysis of macrophages differentiation and activation. Int J Cancer 1996; 66: 645-652.
14. Santini MT, Rainaldi G. Three-dimensional spheroid model in tumor biology. Pathology 1999; 67:148-157.
15. Santini MT, Rainaldi G, Indovina PL. Apoptosis, cell adhesion and extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit Rev Oncol Hematol 2000; 36:75-87.
16. Mariani M, Supino R. Morphological alterations induced by doxorubicin in B16 melanoma cells. Cancer Lett 1990; 51:209-212.
17. Kraal G, Breel M, Janse M, Bruin G. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J Exp Med 1986; 163:981-997.
18. Audran R, Dazord L, Toujas L. Interactions between human macrophages and tumor cells in three-dimensional cultures. Cancer Immunol Immunother 1994; 39:299-304.
19. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992; 13: 265-270.
20. Vaday GG, Hershkoviz R, Rahat MA, Lahat N, Cahalon L, Lider O. Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis. J Leuk Biol 2000; 68:737-747.
21. Silzle T, Kreutz M, Dobler MA, Brockhoff G, Knuechel R, Kunz-Schughart LA. Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur J Immunol 2003; 33:1311-1320.
22. Dumont S, Mabontzo A, Hartmann D, Kessler R, Poindron P, Bartholeyns J. Study of the dependence of human monocytes and macrophages antitumoural properties upon TNF expression or release. Anticancer Res 1990; 10:949-954.
23. Mukouyama H, Janzen NK, Hernandez JM, Lam JS, Caliliw R, Wang AY, et al. Generation of kidney cancer-specific antitumor immune responses using peripheral blood monocytes transduced with a recombinant adenovirus encoding carbonic anhydrase 9. Clin Cancer Res 2004; 10:1421-1429.
24. Candido KA, Shimizu K, McLaughlin JC, Kunkel R, Fuller JA, Redman BG, et al. Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents. Cancer Res 2001; 61:228-236.